Clinical and genetic characterization of nephropathy in patients with nail-patella syndrome

• Published in: European journal of human genetics : EJHG Vol. 28; no. 10; pp. 1414 - 1421
• Main Authors: Harita, Yutaka, Urae, Seiya, Akashio, Riki, Isojima, Tsuyoshi, Miura, Kenichiro, Yamada, Takeshi, Yamamoto, Katsusuke, Miyasaka, Yasunori, Furuyama, Masayuki, Takemura, Tsukasa, Gotoh, Yoshimitsu, Takizawa, Hideki, Tamagaki, Keiichi, Ozawa, Atsushi, Ashida, Akira, Hattori, Motoshi, Oka, Akira, Kitanaka, Sachiko
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.10.2020; Springer International Publishing
• Subjects: End-stage renal disease; Haploinsufficiency; Homeobox; Kidney diseases; LMX1B gene; Nail-patella syndrome; Nails (Anatomy); Nephropathy; Phenotypes; Proteinuria; Renal function
• ISSN: 1018-4813; 1476-5438
• DOI: 10.1038/s41431-020-0655-3

Nail-patella syndrome (NPS) is a multi-system disorder characterized by hypoplastic nails, hypoplastic patella, skeletal deformities, and iliac horns, which is caused by heterozygous variants of LMX1B. Nephropathy ranging from mild urinary abnormality to end-stage renal disease occurs in some individuals with NPS. Because of the low prevalence of NPS and the lack of longitudinal studies of its kidney involvement, the clinical, pathological, and genetic features characterizing severe nephropathy remain unclear. We conducted a Japanese survey of NPS with nephropathy, and analyzed their clinical course, pathological features, and factors associated with severe renal phenotype. LMX1B gene analysis and luciferase reporter assay were also performed. Among 13 NPS nephropathy cases with genetic validation, 5 patients who had moderate-to-massive proteinuria progressed to advanced chronic kidney disease or end-stage renal disease. Pathological findings in the early phase did not necessarily correlate with renal prognosis. Variants associated with deteriorated renal function including a novel variants were confined to the N-terminal region of the LIM domain and a short sequence in the LMX1B homeodomain, which were distinct from reported variants found in isolated nephropathy without extrarenal manifestation (LMX1B-associated nephropathy). Luciferase reporter analysis demonstrated that variants in patients with severe renal phenotype caused haploinsufficiency, but no dominant-negative effects on promoter activation. A distinct proportion of NPS nephropathy patients progressed to end-stage renal disease in adolescence or young adulthood. Patients with moderate or severe proteinuria, especially those with variants in specific regions of LMX1B, should be monitored for potential deterioration of renal function.